Model | Effect of imatinib | Reference |
---|---|---|
In vitro studies | ||
Rat aortic endothelial cells | Protects endothelial barrier | [20] |
Human umbilical vein endothelial cells | Protects endothelial barrier Improves cell-matrix adhesion | [3] |
Human lung microvascular endothelial cells | Protects endothelial barrier | [3] |
Immortalized endothelial cells | Protects endothelial barrier | [9] |
Human umbilical vein endothelial cells | Protects endothelial barrier | [18] |
Mouse lung microvascular endothelial cells | Protects endothelial barrier | [40] |
In vivo studies | ||
Bleomycin-induced lung injury | Anti-inflammatory Anti-fibrotic | [35] |
Isolated perfused lung model (mouse) | Inhibits lung vascular leak | [3] |
Miles assay (mouse) | Attenuates vascular leak in skin | [3] |
Cecal Ligation & Puncture (Sepsis) (mouse) | Attenuates vascular leak in lungs, kidneys | [3] |
Intratracheal LPS (mouse) | Attenuates pulmonary edema | [18] |
Ischemia-reperfusion in reperfusion lung | Reduces endothelial cytotoxicity | [40] |
Miles assay (mouse) | Attenuates vascular leak in skin | [9] |
Intratracheal LPS (mouse) | Attenuates vascular leak and inflammation | [23] |
Cardiac bypass surgery | Attenuates vascular leak, improves perfusion, improves oxygenation | [19] |
Clinical case reports (human) | ||
Pulmonary veno-occlusive disease | Resolution of pulmonary edema Improvement of oxygenation | [30] |
Bleomycin-induced pneumonitis / lung injury | Resolution of pulmonary edema | [8] |
Idiopathic pulmonary vascular leak | Resolution of generalized edema Reduction of pulmonary vascular leak | Aman 2013 |
Drug-induced pneumonitis | Resolution of pneumonitis, case series | [22] |